ASCO has endorsed the “PREVENT HPV Cancers Act” (H.R. 1550), which was recently introduced by Representative Kathy Castor (FL-14). In a recent letter to the lawmaker, ASCO thanked Rep. Castor for introducing this important measure to increase research on, awareness of, and access to the vaccine, which prevents the human papillomavirus (HPV) types that cause most types of cervical cancers as well as some other cancers.
Specifically, H.R. 1550 would:
According to a policy statement from ASCO titled Human Papillomavirus Vaccination for Cancer Prevention, HPV-related cancers are disproportionately distributed among individuals who are living on a lower income, have lower education levels, and are from a racial or ethnic minority group.1 Increased public awareness and immunization initiatives would help improve vaccination rates in these underserved communities. More comprehensive research on the HPV vaccine, as authorized in the PREVENT HPV Cancers Act, would also help better identify these disparities and ways to address them.
1. Bailey HH, Chuang LT, duPont NC, et al: American Society of Clinical Oncology statement: Human papillomavirus vaccination for cancer prevention. J Clin Oncol 34:1803-1812, 2016.
© 2021. American Society of Clinical Oncology. All rights reserved.